NEWS"The communication tools between cells can be used as therapeutics."

27 Dec 2022

For those curious about intrinsic nanovesicle-based therapeutics, Gi-Hoon Nam, CSO (Chief Scientific Officer) of SHIFTBIO INC. has elaborated concisely through an interview.


You can reach out for the full article through the link below:

https://lnkd.in/giyEFrdH